Literature DB >> 25220237

PDYN, a gene implicated in brain/mental disorders, is targeted by REST in the adult human brain.

Richard Henriksson1, Cristina M Bäckman2, Brandon K Harvey3, Helena Kadyrova4, Igor Bazov4, Toni S Shippenberg5, Georgy Bakalkin4.   

Abstract

The dynorphin κ-opioid receptor system is implicated in mental health and brain/mental disorders. However, despite accumulating evidence that PDYN and/or dynorphin peptide expression is altered in the brain of individuals with brain/mental disorders, little is known about transcriptional control of PDYN in humans. In the present study, we show that PDYN is targeted by the transcription factor REST in human neuroblastoma SH-SY5Y cells and that that interfering with REST activity increases PDYN expression in these cells. We also show that REST binding to PDYN is reduced in the adult human brain compared to SH-SY5Y cells, which coincides with higher PDYN expression. This may be related to MIR-9 mediated down-regulation of REST as suggested by a strong inverse correlation between REST and MIR-9 expression. Our results suggest that REST represses PDYN expression in SH-SY5Y cells and the adult human brain and may have implications for mental health and brain/mental disorders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MIR-9; NRSF; PDYN; Prefrontal cortex; REST; SH-SY5Y cell

Mesh:

Substances:

Year:  2014        PMID: 25220237     DOI: 10.1016/j.bbagrm.2014.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Prodynorphin gene promoter polymorphism and temporal lobe epilepsy: A meta-analysis.

Authors:  Na Zhang; Tao-Hui Ouyang; Qing Zhou; Hui-Cong Kang; Sui-Qiang Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

2.  Sex-specific linkage scans in opioid dependence.

Authors:  Bao-Zhu Yang; Shizhong Han; Henry R Kranzler; Abraham A Palmer; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-20       Impact factor: 3.568

Review 3.  Brain REST/NRSF Is Not Only a Silent Repressor but Also an Active Protector.

Authors:  Yangang Zhao; Min Zhu; Yanlan Yu; Linli Qiu; Yuanyuan Zhang; Li He; Jiqiang Zhang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 4.  The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases

Authors:  Pietro Baldelli; Jacopo Meldolesi
Journal:  eNeuro       Date:  2015-07-10

5.  Overexpression of miR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration.

Authors:  Maria Mavrikaki; Eleni Anastasiadou; Recep A Ozdemir; David Potter; Carolin Helmholz; Frank J Slack; Elena H Chartoff
Journal:  Int J Neuropsychopharmacol       Date:  2019-06-03       Impact factor: 5.176

Review 6.  Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System.

Authors:  Xin-Jin Su; Bei-Duo Shen; Kun Wang; Qing-Xin Song; Xue Yang; De-Sheng Wu; Hong-Xing Shen; Chao Zhu
Journal:  Front Cell Dev Biol       Date:  2022-03-01

Review 7.  Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain.

Authors:  Olga Nosova; Igor Bazov; Victor Karpyak; Mathias Hallberg; Georgy Bakalkin
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

8.  MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.

Authors:  Jenica D Tapocik; Kristin Ceniccola; Cheryl L Mayo; Melanie L Schwandt; Matthew Solomon; Bi-Dar Wang; Truong V Luu; Jacqueline Olender; Thomas Harrigan; Thomas M Maynard; Greg I Elmer; Norman H Lee
Journal:  Front Mol Neurosci       Date:  2016-03-24       Impact factor: 5.639

9.  Neuropeptides as the Shared Genetic Crosstalks Linking Periodontitis and Major Depression Disorder.

Authors:  Changsheng Sun; Jiatong Han; Yixin Bai; Zhaowei Zhong; Yingtao Song; Yu Sun
Journal:  Dis Markers       Date:  2021-10-21       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.